Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashvini Keshavan

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 22, 2025
Global multi-specialty clinician perspectives on the implementation of Alzheimer's disease blood biomarkersJoanne Rodda, Lindsey A Kuchenbecker, Wyllians V Borelli, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 1, 2020
Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassaysAshvini Keshavan, Henrietta Wellington, Zhongbo Chen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 13, 2023
Alzheimer's disease marker phospho-tau181 is not elevated in the first year after moderate-to-severe TBINeil Graham, Karl Zimmerman, Amanda J Heslegrave, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 19, 2026
The Alzheimer's Disease Diagnosis and Plasma Phospho-Tau217 (ADAPT) study stage 1: Validating clinical cut-points against CSF and amyloid PETAshvini Keshavan, Katharine Wiltshire, Ryan Wee, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 15, 2019
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive questMartha S Foiani, Claudia Cicognola, Natalia Ermann, et al.
Journal of Neurology|June 26, 2020
Olfactory testing does not predict β-amyloid, MRI measures of neurodegeneration or vascular pathology in the British 1946 birth cohortSarah M Buchanan, Thomas D Parker, Christopher A Lane, et al.
Brain : a Journal of Neurology|October 18, 2024
Associations between accelerated forgetting, amyloid deposition and brain atrophy in older adultsKirsty Lu, John Baker, Jennifer M Nicholas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 9, 2019
Pure tone audiometry and cerebral pathology in healthy older adultsThomas Parker, David M Cash, Chris Lane, et al.
BMJ Open|August 3, 2019
Incidental findings on brain imaging and blood tests: results from the first phase of Insight 46, a prospective observational substudy of the 1946 British birth cohortSarah E Keuss, Thomas D Parker, Christopher A Lane, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 22, 2020
Amyloid β influences the relationship between cortical thickness and vascular loadThomas D Parker, David M Cash, Christopher A Lane, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 22, 2025
Global multi-specialty clinician perspectives on the implementation of Alzheimer's disease blood biomarkersJoanne Rodda, Lindsey A Kuchenbecker, Wyllians V Borelli, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 1, 2020
Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassaysAshvini Keshavan, Henrietta Wellington, Zhongbo Chen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 13, 2023
Alzheimer's disease marker phospho-tau181 is not elevated in the first year after moderate-to-severe TBINeil Graham, Karl Zimmerman, Amanda J Heslegrave, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 19, 2026
The Alzheimer's Disease Diagnosis and Plasma Phospho-Tau217 (ADAPT) study stage 1: Validating clinical cut-points against CSF and amyloid PETAshvini Keshavan, Katharine Wiltshire, Ryan Wee, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 15, 2019
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive questMartha S Foiani, Claudia Cicognola, Natalia Ermann, et al.
Journal of Neurology|June 26, 2020
Olfactory testing does not predict β-amyloid, MRI measures of neurodegeneration or vascular pathology in the British 1946 birth cohortSarah M Buchanan, Thomas D Parker, Christopher A Lane, et al.
Brain : a Journal of Neurology|October 18, 2024
Associations between accelerated forgetting, amyloid deposition and brain atrophy in older adultsKirsty Lu, John Baker, Jennifer M Nicholas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 9, 2019
Pure tone audiometry and cerebral pathology in healthy older adultsThomas Parker, David M Cash, Chris Lane, et al.
BMJ Open|August 3, 2019
Incidental findings on brain imaging and blood tests: results from the first phase of Insight 46, a prospective observational substudy of the 1946 British birth cohortSarah E Keuss, Thomas D Parker, Christopher A Lane, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 22, 2020
Amyloid β influences the relationship between cortical thickness and vascular loadThomas D Parker, David M Cash, Christopher A Lane, et al.
Pageof 7